# Grey Matter Neurosciences

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/grey-matter-neurosciences

- Industry: Medical Devices & Equipment
- Headquarters: Toronto, Canada
- Website: www.greymatterneurosciences.com
- Total disclosed funding: $14M
- Latest round: Seed (Jan 20, 2025)
- Investors on record: 4

## About

Grey Matter Neurosciences focuses on advancing non-invasive therapeutic solutions for cognitive decline. Founded in Canada, the company has raised USD 14.00 mn in Seed funding, led by Wittington Ventures, with participation from Ontario Brain Institute, Ontario Centre of Innovation, and TIAP. The firm has one global office located in Toronto, Canada. The founder's previous entrepreneurial experience is not publicly detailed.

Grey Matter Neurosciences is focused on the innovative development of a portable ultrasound helmet designed to enhance brain function, specifically targeting Alzheimer's disease. This unique product utilizes advanced focused ultrasound technology to provide non-invasive therapeutic solutions aimed at restoring cognitive capabilities in seniors. The helmet is intended for use in clinical environments and potentially at home, catering to elderly patients experiencing early to moderate stages of cognitive decline. By targeting Alzheimer's disease, Grey Matter Neurosciences seeks to address a significant healthcare challenge, providing an accessible solution for patients and their caregivers. The company aims to penetrate markets in North America and Europe, where there is a notable demand for Alzheimer's treatment solutions.

The revenue model for Grey Matter Neurosciences is structured around direct-to-consumer sales and potential partnerships with healthcare providers. The company anticipates revenue generation through the sale of its ultrasound helmet, which will be priced to reflect its innovative technology and the value it offers to users. The sales process involves transactions with healthcare facilities, rehabilitation centers, and direct consumers, creating a streamlined approach to market its flagship product. As the company develops its product, it may also explore subscription models for ongoing support or services related to the use of the ultrasound helmet, thereby establishing a continuing revenue stream from its client base.

In January 2025, Grey Matter Neurosciences raised USD 14.00 mn in Seed funding led by Wittington Ventures, with participation from TIAP, Ontario Brain Institute, and Ontario Centre of Innovation. The company will use the funding to support advanced research on focused ultrasound neuromodulation. Future growth plans include launching the portable ultrasound helmet, specifically designed for treating Alzheimer’s patients, while targeting expansion into North American and European markets by 2026. This strategy reflects a commitment to addressing the healthcare challenges faced by individuals with cognitive decline.

## Funding rounds

- Seed, Jan 20, 2025, $14M — Ontario Centre of Innovation, Wittington Ventures, TIAP, Ontario Brain Institute

## Investors

- Ontario Centre of Innovation (https://capitalatlas.ai/funds/ontario-centre-of-innovation) — Seed
- Wittington Ventures (https://capitalatlas.ai/funds/wittington-ventures) — Seed
- TIAP — Seed
- Ontario Brain Institute — Seed